We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cellectricon Signs Collaboration Agreement with AstraZeneca

News   May 04, 2006

 
Cellectricon Signs Collaboration Agreement with AstraZeneca
 
 
 

RELATED ARTICLES

Uncovering the Structures of Key Drug Targets

News

Researchers have published a review on serial femtosecond crystallography, a promising method for analyzing the tertiary structure of proteins. This technique has rapidly evolved over the past decade, opening new prospects for the rational design of drugs targeting proteins previously inaccessible to structural analysis.

READ MORE

Human Pancreas-on-a-Chip Helps Identify Cause of Cystic Fibrosis Complication

News

Scientists have created human pancreas-on-a-chip that will enable them to identify the possible cause of a frequent and deadly complication of cystic fibrosis called CF-related diabetes, or CFRD.

READ MORE

Accelerating Chemical Synthesis With "Turbo Chip"

News

Researchers have developed a process that facilitates and accelerates chemical synthesis and biological screening by combining all steps on a chip.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE